Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Deep Value
  3. /Chemicals - Inorganic
  4. /Fischer Medical Ventures Ltd
MomentumDeep Value

Fischer Medical Ventures Ltd: Is It a Deep Value Opportunity?

Weak

As of Jul 10, 2026, Fischer Medical Ventures Ltd (Chemicals - Inorganic) has a deep value score of 31/100 (rated Weak). 1Y return vs Nifty 500: -50%.

Fischer Medical Ventures Ltd Key Facts

PE Ratio
81.6x
Market Cap
₹2,531 Cr
Value Score
31/100
Margin of Safety
-50%
PAT Growth YoY
-642%
Revenue Growth YoY
+99%
OPM
1.0%
PE: Cycle BottomStrong Opportunity

What's Happening

💎PE falling while earnings hold — value emerging
💪Debt reduced 72% YoY — balance sheet strengthening
👔Promoter stake down 13.1% this quarter
🌐FII stake increased 0.5% this quarter
💰Trading 50% above estimated fair value — significant premium

Key Numbers

PAT Growth YoY
-642%
Inflection Down
Revenue YoY
+99%
Stable
Operating Margin
1.0%
-408 bps YoY
PE Ratio
81.6
PEG Ratio
0.09
Current Price
₹39
Dividend Yield
0.01%
3Y PAT CAGR
+80%
Market Cap
2.5K Cr
Valuation
Significantly Overvalued

How Fast Is Fischer Medical Ventures Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+99%—Stable
PAT (Net Profit)-642%+80%Inflection Down
OPM1.0%-408 bpsVolatile
← Back to Chemicals - InorganicAll Deep Value SectorsDashboard

Frequently Asked Questions: Fischer Medical Ventures Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What is Fischer Medical Ventures Ltd's deep value score?

Fischer Medical Ventures Ltd has a deep value score of 31/100 (rated Weak). This score is calculated from three components

  • Earnings Score: 9/40 — measures PAT growth momentum across quarters
  • Underperformance Score: 29/35 — how much the stock trails Nifty 500 (deeper underperformance = higher contrarian signal)
  • Quality Score: 0/25 — operational quality (margins, revenue growth, valuation)

Is Fischer Medical Ventures Ltd fundamentally improving?

Fischer Medical Ventures Ltd's quarterly profit (PAT) growth trajectory

  • Latest Quarter PAT Growth (QoQ): -137%
  • Previous Quarter PAT Growth (QoQ): +39%
  • 2 Quarters Ago PAT Growth (QoQ): +177%
  • PAT Acceleration: -157.2pp (profits are decelerating)

Why is Fischer Medical Ventures Ltd underperforming despite good earnings?

Fischer Medical Ventures Ltd is underperforming the market despite improving earnings — this is the core deep value thesis

  • 1-Year Return vs Nifty 500: -50%
  • 6-Month Return vs Nifty 500: -3%
  • 3-Month Return vs Nifty 500: -10%
  • Yet average quarterly PAT growth is +26% — earnings are improving
  • The market often takes time to re-rate stocks with improving fundamentals. This gap between price performance and earnings improvement is what deep value research seeks to identify.

What is the earnings momentum for Fischer Medical Ventures Ltd?

Fischer Medical Ventures Ltd's earnings momentum is Decelerating — growth rate is slowing.

  • PAT QoQ progression: +177% → +39% → -137% (2Q ago → 1Q ago → latest)
  • Acceleration: -157.2pp
  • PAT YoY Growth: -642%

Is Fischer Medical Ventures Ltd undervalued?

Fischer Medical Ventures Ltd's valuation metrics

  • Price-to-Earnings (PE): 78.5x
  • Price-to-Book (PB): 6.5x
  • PEG Ratio: 0.1x
  • Margin of Safety: -50% (appears overvalued)

What are the revenue and margin trends for Fischer Medical Ventures Ltd?

Fischer Medical Ventures Ltd's revenue and margin trends

  • Latest Quarter Revenue Growth (QoQ): -3%
  • Average Quarterly Revenue Growth: +94%
  • Revenue Acceleration: -135.8pp
  • Latest OPM Change: -20.3pp (margins contracting)
  • Average OPM Change: -5.7pp
  • Revenue YoY: +99%

What is Fischer Medical Ventures Ltd's trailing twelve month (TTM) performance?

Fischer Medical Ventures Ltd's trailing twelve month (TTM) performance

  • TTM PAT: ₹31 Cr
  • TTM PAT Growth: +100.0% YoY
  • TTM Revenue: ₹309 Cr
  • TTM Revenue Growth: +100.0% YoY
  • TTM Operating Margin: 13.9%

What sector does Fischer Medical Ventures Ltd belong to?

Fischer Medical Ventures Ltd key facts

  • Sector: Chemicals - Inorganic
  • Market Cap: ₹2.5K Cr
  • Rank in Chemicals - Inorganic: #1 by value score
  • Overall rank among all deep value stocks: #101

Is Fischer Medical Ventures Ltd a good deep value opportunity to study?

Fischer Medical Ventures Ltd shows limited deep value signals currently — score is 31/100 (Weak). Monitor for improvement.

  • Value Score: 31/100 (Weak)
  • Earnings: Not accelerating
  • 1Y Underperformance: -50% vs Nifty 500

What is the bull and bear case for Fischer Medical Ventures Ltd?

Risk Factors (Bear Case)

  • Earnings growth decelerating
  • Significant underperformance (-50% vs Nifty 1Y)
  • Margin pressure warning
  • Operating margins contracting
  • Appears overvalued despite underperformance

How does the Chemicals - Inorganic sector look for deep value?

Chemicals - Inorganic deep value sector overview

  • 1 deep value stock in this sector
  • Average value score: 31/100
  • Avg PAT acceleration: -157.2pp
  • Top pick: Fischer Medical Ventures Ltd

What is deep value investing?

Deep value investing studies stocks that are underperforming the market despite showing improving fundamentals. The thesis is that the market has not yet recognized the earnings recovery, creating a potential valuation gap. It requires patience — recovery can take several quarters.

How is the deep value score calculated?

The deep value score (0-100) combines three factors:

- Earnings (0-40 pts): PAT growth across last 3 quarters, acceleration, and consecutive growth - Underperformance (0-35 pts): How much the stock trails Nifty 500 over 1Y, 6M, 3M (deeper underperformance = higher score) - Quality (0-25 pts): Revenue growth, margin trends, and valuation metrics (PEG, P/B)

Higher score indicates a stronger contrarian research signal.

The above FAQs are generated from publicly available earnings data. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.